Recombinant human thrombopoietin safety and efficacy in pediatric allogeneic hematopoietic stem cell transplantation: A cohort study

doi:10.4252/wjsc.v17.i7.106579

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 7

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (200)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series, Tables (1-4) series.

Item

Count

PDF

HTML

Figures (1-1)

Tables (1-4)

Sum=117

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=55

Publishing Process of This Article

Item

Count

Browse

Download

Sum=19

Jul 26, 2025 (publication date) through Jul 27, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Stem Cells

ISSN

1948-0210

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

World J Stem Cells. Jul 26, 2025; 17(7): 106579
Published online Jul 26, 2025. doi: 10.4252/wjsc.v17.i7.106579

Open in New Tab Full Size Figure Download Figure

Figure 1 Median and median change of platelet after recombinant human thrombopoietin treatment from baseline in patients with hematological diseases in different age groups. A: Median platelet (PLT) over time; B: Median change of PLT from baseline. Data shown are median (Q1, Q3). Numbers under abscissa indicate time (day) after treatment with recombinant human thrombopoietin (rhTPO).

Citation: Li XG, Wang RM, Chen W, Yao T, Chen F, Xu YF, Lang T. Recombinant human thrombopoietin safety and efficacy in pediatric allogeneic hematopoietic stem cell transplantation: A cohort study. World J Stem Cells 2025; 17(7): 106579
URL: https://www.wjgnet.com/1948-0210/full/v17/i7/106579.htm
DOI: https://dx.doi.org/10.4252/wjsc.v17.i7.106579